NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹710 Cr | ₹466 Cr | ₹428 Cr | ₹439 Cr | ₹363 Cr |
What is the latest Total Current Liabilities ratio of NEULAND LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹710 Cr |
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹428 Cr |
| Mar2023 | ₹439 Cr |
| Mar2022 | ₹363 Cr |
How is Total Current Liabilities of NEULAND LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹710 Cr | 52.51 | |
| Mar2025 | ₹466 Cr | 8.89 | |
| Mar2024 | ₹428 Cr | -2.57 | |
| Mar2023 | ₹439 Cr | 20.87 | |
| Mar2022 | ₹363 Cr | - | |
Compare Total Current Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹26,984.6 Cr | 6.1% | 4.4% | 15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 6.1% |
4.4% |
15.5% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses